Health
0
Comments
FDA Approves Flibanserin 'Little Pink Pill' Amid Controversy
The FDA has given the green light to Addyi, also known as the 'little pink pill' or flibanserin, designed to boost women's sexual desire. The approval follows an intense lobbying campaign and comes with several prescribing restrictions. Although hailed as a breakthrough for treating Hypoactive Sexual Desire Disorder (HSDD), the drug's effectiveness and safety remain points of contention among experts.
About
Health
Latest Posts
Exploring the Best Alternatives to Propecia for Hair Loss in 2024
By Orion Kingsworth Oct 19, 2024
Acotiamide and Pregnancy: What You Need to Know
By Orion Kingsworth May 19, 2023
Sweet Violet: The Natural Dietary Supplement to Support Your Health Goals
By Orion Kingsworth Aug 1, 2023
